Diabetic Retinopathy as a Predictor of Angiographic Coronary Atherosclerosis Severity in Patients with Type 2 Diabetes Mellitus

References

• Chen XD, Gardner TW. A critical review: psychophysical assessments of diabetic retinopathy. Surv Ophthalmol. 2021;66(2):213–230. doi:10.1016/j.survophthal.2020.08.003
   Web of Science ®Google Scholar
• Yau JW, Rogers SL, Kawasaki R, et al. Global prevalence and major risk factors of diabetic retinopathy. Diabetes Care. 2012;35(3):556–564. doi:10.2337/dc11-1909
   PubMed Web of Science ®Google Scholar
• Go AS, Mozafarian D, Roger VL, et al. Executive summary: heart disease and stroke statistics—2013 update: a report from the American Heart Association. Circulation. 2013;127(1):143–152. doi:10.1161/CIR.0b013e318282ab8f
   PubMed Web of Science ®Google Scholar
• Petrie JR, Guzik TJ, Touyz RM. Diabetes, hypertension, and cardiovascular disease: clinical insights and vascular mechanisms. Can J Cardiol. 2018;34(5):575–584. doi:10.1016/j.cjca.2017.12.005
   PubMed Web of Science ®Google Scholar
• O’Keefe JH, Carter MD, Lavie CJ. Primary and secondary prevention of cardiovascular diseases: a practical evidence-based approach. Mayo Clin Proc. 2009;84(8):741–757. doi:10.1016/s0025-6196(11)60525-9
   Web of Science ®Google Scholar
• Pradeepa R, Surendar J, Indulekha K, Chella S, Anjana RM, Mohan V. Relationship of diabetic retinopathy with coronary artery disease in Asian Indians with type 2 diabetes: the Chennai Urban Rural Epidemiology Study (CURES) Eye Study—3. Diabetes Technol Ther. 2015;17(2):112–118. doi:10.1089/dia.2014.0141
   Web of Science ®Google Scholar
• Zhu XR, Zhang YP, Bai L, Zhang XL, Zhou JB, Yang JK. Prediction of risk of diabetic retinopathy for all-cause mortality, stroke and heart failure: evidence from epidemiological observational studies. Medicine. 2017;96(3):e5894. doi:10.1097/MD.0000000000005894
   PubMed Web of Science ®Google Scholar
• Um T, Lee DH, Kang JW, Kim EY, Yoon YH. The degree of diabetic retinopathy in patients with type 2 diabetes correlates with the presence and severity of coronary heart disease. J Korean Med Sci. 2016;31(8):1292–1299. doi:10.3346/jkms.2016.31.8.1292
   Web of Science ®Google Scholar
• Juutilainen A, Lehto S, Ronnemaa T, Pyorala K, Laakso M. Retinopathy predicts cardiovascular mortality in type 2 diabetic men and women. Diabetes Care. 2007;30(2):292–299.
   Web of Science ®Google Scholar
• Targher G, Bertolini L, Tessari R, Zenari L, Arcaro G. Retinopathy predicts future cardiovascular events among type 2 diabetic patients: the Valpo‑licella Heart Diabetes Study. Diabetes Care. 2006;29(5):1178. doi:10.2337/diacare.2951178
   Web of Science ®Google Scholar
• El-hefny E, Tag El-Din A, Sadek A, Abbas E. The degree of retinopathy correlates with the presence of silent myocardial ischemia in diabetic patients. Eur Heart J. 2020;41:ehaa946.3048. doi:10.1093/ehjci/ehaa946.3048.
   Web of Science ®Google Scholar
• Saif A, Karawya S, Abdelhamid A. Retinopathy is a strong determinant of atherosclerosis in type 2 diabetes mellitus: correlation with carotid intima-media thickness. Endocr Pract. 2015;21(3):226–230. PMID: 25370328. doi:10.4158/EP14390.OR
   Web of Science ®Google Scholar
• Jellinger PS, Handelsman Y, Rosenblit PD, et al. American Association of Clinical Endocrinologists and American College of Endocrinology guidelines for management of dyslipidemia and prevention of cardiovascular disease. Endocr Pract. 2017;23:1–87. doi:10.4158/EP171764.APPGL
   PubMed Web of Science ®Google Scholar
• Kenneth FAS, Harris TB, Harris TB, et al. Overweight, obesity, and mortality in a large prospective cohort of persons 50 to 71 years old. N Engl J Med. 2006;355(8):763–778. doi:10.1056/NEJMoa055643
   Web of Science ®Google Scholar
• Levey AS, Stevens LA, Schmid CH, et al. a new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150(9):604–612. doi:10.7326/0003-4819
   PubMed Web of Science ®Google Scholar
• Scott MG, Neil JS, Alison LB, et al. AHA/ACC/AACVPR/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA guidelines on the management of blood cholesterol: a report from the American College of Cardiology/American Heart Association Task Force on clinical practice guidelines. J Am Coll. 2019;73(24):e285–e350.
   Web of Science ®Google Scholar
• Flaxel CJ, Adelman RA, Bailey ST, et al. Diabetic retinopathy preferred practice pattern®. Ophthalmology. 2020;127(1):66–145.
   Web of Science ®Google Scholar
• Seldinger SI. Catheter replacement of the needle in percutaneous arteriography: a new technique. Acta Radiol. 1953;39(5):370. doi:10.3109/00016925309136722
   Web of Science ®Google Scholar
• Gensini GG. A more meaningful scoring system for determining the severity of coronary heart disease. Am J Cardiol. 1983;51:606. doi:10.1016/S0002-9149(83)80105-2
   PubMed Web of Science ®Google Scholar
• Jibran MS, Zahid ZU, Habib SA. Diabetic retinopathy as a predictor of severity of coronary artery disease. Khyber Med Univ J. 2018;10(4):188–191.
   Google Scholar
• Barkoudah E, Skali H, Uno H, Solomon SD, Pfeffer MA. Mortality rates in trials of subjects with type 2 diabetes. J Am Heart Assoc. 2012;1(1):e000059. doi:10.1161/JAHA.111.000059
   Web of Science ®Google Scholar
• Cheung N, Wang JJ, Klein R, et al. Diabetic retinopathy and the risk of coronary heart disease: the Atherosclerosis Risk in Communities Study. Diabetes Care. 2007;30(7):1742–1746. doi:10.2337/dc07-0264
   PubMed Web of Science ®Google Scholar
• Targher G, Bertolini L, Zenari L, et al. Diabetic retinopathy is associated with an increased incidence of cardiovascular events in type 2 diabetic patients. Diabetic Med. 2008;25:45–50. doi:10.1111/j.1464-5491.2007.02327.x
   PubMed Web of Science ®Google Scholar
• Gerstein HC, Ambrosius WT, Danis R, et al. Diabetic retinopathy, its progression, and incident cardiovascular events in the ACCORD trial. Diabetes Care. 2013;36(5):1266–1271. doi:10.2337/dc12-1311
   Web of Science ®Google Scholar
• Alonso N, Traveset A, Rubinat E, et al. Type 2 diabetes-associated carotid plaque burden is increased in patients with retinopathy compared to those without retinopathy. Cardiovasc Diabetol. 2015;14(1):1–9. doi:10.1186/s12933-015-0196-1
   Web of Science ®Google Scholar
• de Kreutzenberg SV, Coracina A, Volpi A, et al. Microangiopathy is independently associated with presence, severity and composition of carotid atherosclerosis in type 2 diabetes. Nutr Metab Cardiovasc Dis. 2011;21(4):286–293.
   Web of Science ®Google Scholar
• Kurihara O, Takano M, Mizuno K, et al. Impact of diabetic retinopathy on vulnerability of atherosclerotic coronary plaque and incidence of acute coronary syndrome. Am J Cardiol. 2016;118(7):944–949. doi:10.1016/j.amjcard.2016.06.060
   Web of Science ®Google Scholar
• Gerstein HC, Nair V, Chaube R, Stoute H, Werstuck G. Dysglycemia and the density of the coronary vasa vasorum. Diabetes Care. 2019;42(5):980–982. doi:10.2337/dc18-2483
   Web of Science ®Google Scholar
• Sedding DG, Boyle EC, Demandt JA, et al. Vasa vasorum angiogenesis: key player in the initiation and progression of atherosclerosis and potential target for the treatment of cardiovascular disease. Front Immunol. 2018;9:706. doi:10.3389/fimmu.2018.00706
   PubMed Web of Science ®Google Scholar
• Halon DA, Azencot M, Rubinshtein R, Zafrir B, Flugelman MY, Lewis BS. Coronary computed tomography (CT) angiography as a predictor of cardiac and noncardiac vascular events in asymptomatic type 2 diabetics: a 7‐year population‐based cohort study. J Am Heart Assoc. 2016;5(6):e003226. doi:10.1161/JAHA.116.003226
   Web of Science ®Google Scholar
• Lee KY, Hwang BH, Kim TH, et al. Computed tomography angiography images of coronary artery stenosis provide a better prediction of risk than traditional risk factors in asymptomatic individuals with type 2 diabetes: a long-term study of clinical outcomes. Diabetes Care. 2017;40(9):1241–1248. doi:10.2337/dc16-1844
   Web of Science ®Google Scholar
• Attia MA, Elraghy MI, Elgazar AF, Nayel SR. Correlation between diabetic retinopathy and the severity of coronary artery disease determined by coronary angiography in patients with type II diabetes mellitus. Int J Med Arts. 2020;2(1):204–210.
   Google Scholar
• Shereef AS, Kandeel NT. The relation between retinopathy grade and coronary artery disease in acute coronary syndrome diabetics. J Indian Coll Cardiol. 2019;9:83–87. doi:10.4103/JICC.JICC_24_19
   Google Scholar
• Rong J, Yu CQ, Yang P, Chen J. Association of retinopathy with coronary atherosclerosis determined by coronary 64-slice multidetector computed tomography angiography in type 2 diabetes. Diab Vasc Dis Res. 2013;10(2):161–168. PMID: 22906861. doi:10.1177/1479164112454755
   Web of Science ®Google Scholar
• Aso Y, Inukai T, Tayama K, Takemura Y. Serum concentrations of advanced glycation endproducts are associated with the development of atherosclerosis as well as diabetic microangiopathy in patients with type 2 diabetes. Acta Diabetol. 2000;37(2):87‑92. doi:10.1007/s005920070025
   Web of Science ®Google Scholar
• Wang R, Kudo M, Yokoyama M, Asano G. Roles of advanced glycation endproducts (AGE) and receptor for AGE on vascular smooth muscle cell growth. J Nippon Med Sch. 2001;68(6):472‑81. doi:10.1272/jnms.68.472
   Google Scholar
• Shah K, Natarajan S, Phadke M, Swami OC. Diabetic retinopathy grade as a predictive marker of severity of cardiovascular disease and mortality: DIVERSE Study Group. Int J Diabetes Dev Ctries. 2019;39(2):291–296. doi:10.1007/s13410018-0699-x
   Web of Science ®Google Scholar